-
1
-
-
0029347062
-
New insights into proteasome function: From archaebacteria to drug development
-
Goldberg, A. L., Stein, R., and Adams, J. (1995) New insights into proteasome function: from archaebacteria to drug development. Chem. Biol. 2, 503-508
-
(1995)
Chem. Biol
, vol.2
, pp. 503-508
-
-
Goldberg, A.L.1
Stein, R.2
Adams, J.3
-
2
-
-
0030016595
-
Structure and functions of the 20S and 26S proteasomes
-
Coux, O., Tanaka, K., and Goldberg, A. L. (1996) Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801-847
-
(1996)
Annu. Rev. Biochem
, vol.65
, pp. 801-847
-
-
Coux, O.1
Tanaka, K.2
Goldberg, A.L.3
-
3
-
-
18344394135
-
Proteasome inhibition in the treatment of cancer
-
Richardson, P. G., Mitsiades, C., Hideshima, T., and Anderson, K. C. (2005) Proteasome inhibition in the treatment of cancer. Cell Cycle 4, 290-296
-
(2005)
Cell Cycle
, vol.4
, pp. 290-296
-
-
Richardson, P.G.1
Mitsiades, C.2
Hideshima, T.3
Anderson, K.C.4
-
4
-
-
0037342895
-
Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines
-
Ling, Y. H., Liebes, L., Jiang, J. D., Holland, J. F., Elliott, P. J., Adams, J., Muggia, F. M., and Perez-Soler, R. (2003) Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. Clin. Cancer Res. 9, 1145-1154
-
(2003)
Clin. Cancer Res
, vol.9
, pp. 1145-1154
-
-
Ling, Y.H.1
Liebes, L.2
Jiang, J.D.3
Holland, J.F.4
Elliott, P.J.5
Adams, J.6
Muggia, F.M.7
Perez-Soler, R.8
-
5
-
-
0035328584
-
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: Implications for systemic nuclear factor-κB inhibition
-
Cusack, J. C. Jr., Liu, R., Houston, M., Abendroth, K., Elliott, P. J., Adams, J., and Baldwin, A. S. Jr. (2001) Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-κB inhibition. Cancer Res. 61, 3535-3540
-
(2001)
Cancer Res
, vol.61
, pp. 3535-3540
-
-
Cusack Jr., J.C.1
Liu, R.2
Houston, M.3
Abendroth, K.4
Elliott, P.J.5
Adams, J.6
Baldwin Jr., A.S.7
-
6
-
-
0032885416
-
The proteasome inhibitor PS-341 in cancer therapy
-
Teicher, B. A., Ara, G., Herbst, R., Palombella, V. J., and Adams, J. (1999) The proteasome inhibitor PS-341 in cancer therapy. Clin. Cancer Res. 5, 2638-2645
-
(1999)
Clin. Cancer Res
, vol.5
, pp. 2638-2645
-
-
Teicher, B.A.1
Ara, G.2
Herbst, R.3
Palombella, V.J.4
Adams, J.5
-
7
-
-
29244454269
-
Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis
-
Nawrocki, S. T., Carew, J. S., Pino, M. S., Highshaw, R. A., Dunner, K. Jr., Huang, P., Abbruzzese, J. L., and McConkey, D. J. (2005) Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res. 65, 11658-11666
-
(2005)
Cancer Res
, vol.65
, pp. 11658-11666
-
-
Nawrocki, S.T.1
Carew, J.S.2
Pino, M.S.3
Highshaw, R.A.4
Dunner Jr., K.5
Huang, P.6
Abbruzzese, J.L.7
McConkey, D.J.8
-
8
-
-
0035300479
-
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells
-
Hideshima, T., Richardson, P., Chauhan, D., Palombella, V. J., Elliott, P. J., Adams, J., and Anderson, K. C. (2001) The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 61, 3071-3076
-
(2001)
Cancer Res
, vol.61
, pp. 3071-3076
-
-
Hideshima, T.1
Richardson, P.2
Chauhan, D.3
Palombella, V.J.4
Elliott, P.J.5
Adams, J.6
Anderson, K.C.7
-
9
-
-
14544303662
-
Proteasome inhibition as a novel therapeutic target in human cancer
-
Rajkumar, S. V., Richardson, P. G., Hideshima, T., and Anderson, K. C. (2005) Proteasome inhibition as a novel therapeutic target in human cancer. J. Clin. Oncol. 23, 630-639
-
(2005)
J. Clin. Oncol
, vol.23
, pp. 630-639
-
-
Rajkumar, S.V.1
Richardson, P.G.2
Hideshima, T.3
Anderson, K.C.4
-
10
-
-
39749136204
-
BCL-2 family regulation by the 20S proteasome inhibitor bortezomib
-
Fennell, D. A., Chacko, A., and Mutti, L. (2008) BCL-2 family regulation by the 20S proteasome inhibitor bortezomib. Oncogene 27, 1189-1197
-
(2008)
Oncogene
, vol.27
, pp. 1189-1197
-
-
Fennell, D.A.1
Chacko, A.2
Mutti, L.3
-
11
-
-
34547692973
-
Incorporating bortezomib into the treatment of lung cancer
-
Davies, A. M., Lara, P. N. Jr., Mack, P. C., and Gandara, D. R. (2007) Incorporating bortezomib into the treatment of lung cancer. Clin. Cancer Res. 13, s4647-4651
-
(2007)
Clin. Cancer Res
, vol.13
-
-
Davies, A.M.1
Lara Jr., P.N.2
Mack, P.C.3
Gandara, D.R.4
-
12
-
-
0034902354
-
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma
-
Sunwoo, J. B., Chen, Z., Dong, G., Yeh, N., Crowl Bancroft, C., Sausville, E., Adams, J., Elliott, P., and Van Waes, C. (2001) Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin. Cancer Res. 7, 1419-1428
-
(2001)
Clin. Cancer Res
, vol.7
, pp. 1419-1428
-
-
Sunwoo, J.B.1
Chen, Z.2
Dong, G.3
Yeh, N.4
Crowl Bancroft, C.5
Sausville, E.6
Adams, J.7
Elliott, P.8
Van Waes, C.9
-
13
-
-
0029874138
-
The NF-κB and IκB proteins: New discoveries and insights
-
Baldwin, A. S. Jr. (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683
-
(1996)
Annu. Rev. Immunol
, vol.14
, pp. 649-683
-
-
Baldwin Jr., A.S.1
-
14
-
-
0030615201
-
Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
-
Barnes, P. J., and Karin, M. (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066-1071
-
(1997)
N. Engl. J. Med
, vol.336
, pp. 1066-1071
-
-
Barnes, P.J.1
Karin, M.2
-
15
-
-
0031897632
-
NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
-
Ghosh, S., May, M. J., and Kopp, E. B. (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260
-
(1998)
Annu. Rev. Immunol
, vol.16
, pp. 225-260
-
-
Ghosh, S.1
May, M.J.2
Kopp, E.B.3
-
16
-
-
0034709458
-
NF-κB activation is related to the resistance of lung cancer cells to TNFα-induced apoptosis
-
Kim, J. Y., Lee, S., Hwangbo, B., Lee, C. T., Kim, Y. W., Han, S. K., Shim, Y. S., and Yoo, C. G. (2000) NF-κB activation is related to the resistance of lung cancer cells to TNFα-induced apoptosis. Biochem. Biophys. Res. Commun. 273, 140-146
-
(2000)
Biochem. Biophys. Res. Commun
, vol.273
, pp. 140-146
-
-
Kim, J.Y.1
Lee, S.2
Hwangbo, B.3
Lee, C.T.4
Kim, Y.W.5
Han, S.K.6
Shim, Y.S.7
Yoo, C.G.8
-
17
-
-
0035173922
-
Anti-inflammatory effect of adenovirus-mediated IκBα overexpression in respiratory epithelial cells
-
Park, G. Y., Le, S., Park, K. H., Le, C. T., Kim, Y. W., Han, S. K., Shim, Y. S., and Yoo, C. G. (2001) Anti-inflammatory effect of adenovirus-mediated IκBα overexpression in respiratory epithelial cells. Eur. Respir. J. 18, 801-809
-
(2001)
Eur. Respir. J
, vol.18
, pp. 801-809
-
-
Park, G.Y.1
Le, S.2
Park, K.H.3
Le, C.T.4
Kim, Y.W.5
Han, S.K.6
Shim, Y.S.7
Yoo, C.G.8
-
18
-
-
0034657795
-
Anti-inflammatory effect of heat shock protein induction is related to stabilization of IκBα through preventing IκB kinase activation in respiratory epithelial cells
-
Yoo, C. G., Lee, S., Lee, C. T., Kim, Y. W., Han, S. K., and Shim, Y. S. (2000) Anti-inflammatory effect of heat shock protein induction is related to stabilization of IκBα through preventing IκB kinase activation in respiratory epithelial cells. J. Immunol. 164, 5416-5423
-
(2000)
J. Immunol
, vol.164
, pp. 5416-5423
-
-
Yoo, C.G.1
Lee, S.2
Lee, C.T.3
Kim, Y.W.4
Han, S.K.5
Shim, Y.S.6
-
19
-
-
38949108670
-
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
-
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151-175
-
(2008)
Autophagy
, vol.4
, pp. 151-175
-
-
Klionsky, D.J.1
Abeliovich, H.2
Agostinis, P.3
Agrawal, D.K.4
Aliev, G.5
-
20
-
-
4043050142
-
The heat-shock-induced suppression of the IκB/NF-κB cascade is due to inactivation of upstream regulators of IκBα through insolubilization
-
Lee, K. H., Hwang, Y. H., Lee, C. T., Kim, Y. W., Han, S. K., Shim, Y. S., and Yoo, C. G. (2004) The heat-shock-induced suppression of the IκB/NF-κB cascade is due to inactivation of upstream regulators of IκBα through insolubilization. Exp. Cell Res. 299, 49-56
-
(2004)
Exp. Cell Res
, vol.299
, pp. 49-56
-
-
Lee, K.H.1
Hwang, Y.H.2
Lee, C.T.3
Kim, Y.W.4
Han, S.K.5
Shim, Y.S.6
Yoo, C.G.7
-
21
-
-
25444530592
-
Glycogen synthase kinase 3β functions to specify gene-specific, NF-κB-dependent transcription
-
Steinbrecher, K. A., Wilson, W., 3rd., Cogswell, P. C., and Baldwin, A. S. (2005) Glycogen synthase kinase 3β functions to specify gene-specific, NF-κB-dependent transcription. Mol. Cell. Biol. 25, 8444-8455
-
(2005)
Mol. Cell. Biol
, vol.25
, pp. 8444-8455
-
-
Steinbrecher, K.A.1
Wilson III, W.2
Cogswell, P.C.3
Baldwin, A.S.4
-
22
-
-
4644316230
-
Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine- induced apoptosis
-
Denlinger, C. E., Rundall, B. K., Keller, M. D., and Jones, D. R. (2004) Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine- induced apoptosis. Ann. Thorac. Surg. 78, 1207-1214
-
(2004)
Ann. Thorac. Surg
, vol.78
, pp. 1207-1214
-
-
Denlinger, C.E.1
Rundall, B.K.2
Keller, M.D.3
Jones, D.R.4
-
23
-
-
33746840548
-
Proteasome inhibitors induce death but activate NF-κB on endometrial carcinoma cell lines and primary culture explants
-
Dolcet, X., Llobet, D., Encinas, M., Pallares, J., Cabero, A., Schoenenberger, J. A., Comella, J. X., and Matias-Guiu, X. (2006) Proteasome inhibitors induce death but activate NF-κB on endometrial carcinoma cell lines and primary culture explants. J. Biol. Chem. 281, 22118-22130
-
(2006)
J. Biol. Chem
, vol.281
, pp. 22118-22130
-
-
Dolcet, X.1
Llobet, D.2
Encinas, M.3
Pallares, J.4
Cabero, A.5
Schoenenberger, J.A.6
Comella, J.X.7
Matias-Guiu, X.8
-
24
-
-
1642538959
-
Proteasome inhibitors induce inhibitory κb (IκB) kinase activation, IκBα degradation, and nuclear factor κb activation in HT-29 cells
-
Németh, Z. H., Wong, H. R., Odoms, K., Deitch, E. A., Szabó, C., Vizi, E. S., and Haskó, G. (2004) Proteasome inhibitors induce inhibitory κB (IκB) kinase activation, IκBα degradation, and nuclear factor κB activation in HT-29 cells. Mol. Pharmacol. 65, 342-349
-
(2004)
Mol. Pharmacol
, vol.65
, pp. 342-349
-
-
Németh, Z.H.1
Wong, H.R.2
Odoms, K.3
Deitch, E.A.4
Szabó, C.5
Vizi, E.S.6
Haskó, G.7
-
25
-
-
0031570757
-
Calpain contributes to silica-induced IκB-α degradation and nuclear factor-κB activation
-
Chen, F., Lu, Y., Kuhn, D. C., Maki, M., Shi, X., Sun, S. C., and Demers, L. M. (1997) Calpain contributes to silica-induced IκB-α degradation and nuclear factor-κB activation. Arch. Biochem. Biophys. 342, 383-388
-
(1997)
Arch. Biochem. Biophys
, vol.342
, pp. 383-388
-
-
Chen, F.1
Lu, Y.2
Kuhn, D.C.3
Maki, M.4
Shi, X.5
Sun, S.C.6
Demers, L.M.7
-
26
-
-
0031594708
-
Novel IκBα proteolytic pathway in WEHI231 immature B cells
-
Miyamoto, S., Seufzer, B. J., and Shumway, S. D. (1998) Novel IκBα proteolytic pathway in WEHI231 immature B cells. Mol. Cell. Biol. 18, 19-29
-
(1998)
Mol. Cell. Biol
, vol.18
, pp. 19-29
-
-
Miyamoto, S.1
Seufzer, B.J.2
Shumway, S.D.3
-
27
-
-
0029736796
-
Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of IκB-α in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins
-
White, D. W., and Gilmore, T. D. (1996) Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of IκB-α in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. Oncogene 13, 891-899
-
(1996)
Oncogene
, vol.13
, pp. 891-899
-
-
White, D.W.1
Gilmore, T.D.2
-
28
-
-
0031595780
-
IκB is a substrate for a selective pathway of lysosomal proteolysis
-
Cuervo, A. M., Hu, W., Lim, B., and Dice, J. F. (1998) IκB is a substrate for a selective pathway of lysosomal proteolysis. Mol. Biol. Cell 9, 1995-2010
-
(1998)
Mol. Biol. Cell
, vol.9
, pp. 1995-2010
-
-
Cuervo, A.M.1
Hu, W.2
Lim, B.3
Dice, J.F.4
-
29
-
-
77952340703
-
Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IκB(α) degradation
-
Li, C., Chen, S., Yue, P., Deng, X., Lonial, S., Khuri, F. R., and Sun, S. Y. (2010) Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IκB(α) degradation. J. Biol. Chem. 285, 16096-16104
-
(2010)
J. Biol. Chem
, vol.285
, pp. 16096-16104
-
-
Li, C.1
Chen, S.2
Yue, P.3
Deng, X.4
Lonial, S.5
Khuri, F.R.6
Sun, S.Y.7
-
30
-
-
0036020941
-
NF-κB as a therapeutic target in cancer
-
Orlowski, R. Z., and Baldwin, A. S., Jr. (2002) NF-κB as a therapeutic target in cancer. Trends Mol. Med. 8, 385-389
-
(2002)
Trends Mol. Med
, vol.8
, pp. 385-389
-
-
Orlowski, R.Z.1
Baldwin Jr., A.S.2
-
31
-
-
0242664121
-
IκB kinase-independent IκBα degradation pathway: Functional NF-κB activity and implications for cancer therapy
-
Tergaonkar, V., Bottero, V., Ikawa, M., Li, Q., and Verma, I. M. (2003) IκB kinase-independent IκBα degradation pathway: functional NF-κB activity and implications for cancer therapy. Mol. Cell. Biol. 23, 8070-8083
-
(2003)
Mol. Cell. Biol
, vol.23
, pp. 8070-8083
-
-
Tergaonkar, V.1
Bottero, V.2
Ikawa, M.3
Li, Q.4
Verma, I.M.5
-
32
-
-
0037383322
-
GSK-3: Tricks of the trade for a multi-tasking kinase
-
Doble, B. W., and Woodgett, J. R. (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186
-
(2003)
J. Cell Sci
, vol.116
, pp. 1175-1186
-
-
Doble, B.W.1
Woodgett, J.R.2
-
33
-
-
0038044650
-
Glycogen synthase kinase 3β-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor κb signaling
-
Sanchez, J. F., Sniderhan, L. F., Williamson, A. L., Fan, S., Chakraborty- Sett, S., and Maggirwar, S. B. (2003) Glycogen synthase kinase 3β-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor κB signaling. Mol. Cell. Biol. 23, 4649-4662
-
(2003)
Mol. Cell. Biol
, vol.23
, pp. 4649-4662
-
-
Sanchez, J.F.1
Sniderhan, L.F.2
Williamson, A.L.3
Fan, S.4
Chakraborty- Sett, S.5
Maggirwar, S.B.6
-
34
-
-
24644518476
-
Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-α
-
Eto, M., Kouroedov, A., Cosentino, F., and Lüscher, T. F. (2005) Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-α. Circulation 112, 1316-1322
-
(2005)
Circulation
, vol.112
, pp. 1316-1322
-
-
Eto, M.1
Kouroedov, A.2
Cosentino, F.3
Lüscher, T.F.4
-
35
-
-
4544341116
-
Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor
-
Takada, Y., Fang, X., Jamaluddin, M. S., Boyd, D. D., and Aggarwal, B. B. (2004) Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 279, 39541-39554
-
(2004)
J. Biol. Chem
, vol.279
, pp. 39541-39554
-
-
Takada, Y.1
Fang, X.2
Jamaluddin, M.S.3
Boyd, D.D.4
Aggarwal, B.B.5
-
36
-
-
0036081578
-
Role of glycogen synthase kinase- 3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes
-
Schwabe, R. F., and Brenner, D. A. (2002) Role of glycogen synthase kinase- 3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G204-G211
-
(2002)
Am. J. Physiol. Gastrointest. Liver Physiol
, vol.283
-
-
Schwabe, R.F.1
Brenner, D.A.2
|